|
Supplementary Protection Certificate (SPC) Summary of Applications |
|||
| SPC No. | 2016/042 | ||
|---|---|---|---|
| Date of filing | 24/10/2016 | ||
| Notification of Application Published | 16/11/2016 | ||
| Status | Withdrawn | ||
| Notification of Grant Published | |||
| Date of Expiry of SPC | |||
| Applicant |
GENENTECH, Inc. 1 DNA Way South San Francisco CA 94080-4990 UNITED STATES OF AMERICA |
||
| Patent Number | 1641822 | ||
| Title of Invention | IL-17 A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF | ||
| Date of Expiry of Patent | 01/06/2024 | ||
| Product Type | Medicinal Product | ||
| Product Identity | Ixekizumab | ||
| Market Authorisation | Ireland | ||
| Authorisation No | EU/1/15/1085 | ||
| Authorisation Date | 25/04/2016 | ||
| Identity of Product Authorised | Ixekizumab | ||
| Address for Service |
F.F. GORMAN & CO. 15 Clanwilliam Square Dublin 2 IRELAND |
||
| Renewal Fees | |||
| 26/10/2016 | Request for grant a Supplementary Protection Certificate filed on 24/10/2016, numbered 2016/042. | ||
| 17/04/2020 | Request for grant of Supplementary Protection Certificate No. 2016/042 withdrawn on 17/04/2020. | ||